Article
D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine.
Molecular psychiatry - 1 Jan 2003
Potkin S G, Basile V S, Jin Y, Masellis M, Badri F, Keator D, Wu J C, Alva G, Carreon D T, Bunney W E, Fallon J H, Kennedy J L
Abstract excerpt
A goal of pharmacogenetics is to clarify associations between allelic variation and risk factors in psychiatric illness. We report changes in regional brain metabolism based on dopamine alleles. Treatment-resistant schizophrenic subjects were positron emission tomography scanned with 18F-fluorodeoxyglucose after 5 weeks each of placebo and clozapine treatment. Significant regional brain metabolic effects were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
